Document is current

Any future updates will be listed below

Re-engineering a neuroprotective, clinical drug as a procognitive agent with high in vivo potency and with GABAA potentiating activity for use in dementia

Crossref DOI link: https://doi.org/10.1186/s12868-015-0208-9

Published Online: 2015-10-19

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark